Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Regular ✕Edelweiss Recently Listed IPO Fund · Regular ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundEdelweiss Recently Listed IPO Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseNippon IndiaEdelweiss
NAV₹591.2429₹33.4822
NAV date20 Nov 202620 Nov 2026
History20.6 years8.7 years
Expense ratio1.8%2.7%
Stars★★★★★★★★★★
Growth Score78.1044.70

Returns

Nippon India Pharma FundEdelweiss Recently Listed IPO Fund
1 month+11.32%+5.80%
3 months+3.52%+2.08%
6 months+8.09%+19.60%
YTD+16.05%+23.82%
1 year+14.27%+22.21%
3 years (CAGR)+16.91%+15.66%
5 years (CAGR)+14.37%+9.59%
10 years (CAGR)+15.58%—
Since launch+17.64%+14.82%

Risk

Nippon India Pharma FundEdelweiss Recently Listed IPO Fund
Volatility14.1%20.9%
Downside volatility9.1%13.1%
Sharpe0.740.44
Sortino1.150.70
Calmar1.140.63
Return / risk1.200.75
Deepest fall−47.36%−32.34%
Days to recover301155
Below its high+0.00%−1.65%

Against benchmark

Nippon India Pharma FundEdelweiss Recently Listed IPO Fund
Alpha−2.75%+4.43%
Beta0.890.97
R²89.5%56.3%
Up capture83.5%111.0%
Down capture91.2%96.2%
Tracking error4.8%13.8%
Information ratio−0.880.31
Treynor0.110.09

Consistency

Nippon India Pharma FundEdelweiss Recently Listed IPO Fund
Best 1-year+175.79%+97.69%
Middle 1-year+13.84%+16.18%
Worst 1-year−36.67%−24.34%
1-year periods with a loss23.4%26.2%
Middle 3-year+20.93%+17.58%
Positive months63.9%66.7%
Best day+3.40%+3.68%
Worst day−3.21%−5.79%
Worst 5% day−1.38%−1.94%
Positive days53.7%57.4%
NAVs a year247247

SIP of ₹10,000 a month

Nippon India Pharma FundEdelweiss Recently Listed IPO Fund
5-year XIRR+17.18%+16.40%
5-year value₹9,29,284₹9,11,471
3-year XIRR+13.26%+16.90%
1-year XIRR+21.05%+33.64%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth